Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

High RiskFDA Drug
Medications & Supplements/Dietary Supplements

Infla-650 Dietary Supplement Recalled for Undeclared Drug Ingredients

Agency Publication Date: September 23, 2024
Share:
Sign in to monitor this recall

Summary

Guru Inc. is voluntarily recalling its Infla-650 Herbal Dietary Supplement (700mg) because FDA testing discovered it contains undeclared drugs, including acetaminophen, diclofenac, and phenylbutazone. The product is packaged in pouches containing 60 capsules and was sold nationwide in the United States and at retail stores in South Carolina, North Carolina, and Ohio. Consumers should not use this product as these hidden drug ingredients can lead to serious health complications.

Risk

The undeclared ingredients acetaminophen, diclofenac, and phenylbutazone can cause severe health issues including liver damage, gastrointestinal bleeding, and life-threatening blood disorders. These risks are significantly increased if consumers unknowingly combine this supplement with other medications containing similar drugs.

What You Should Do

  1. This recall affects Infla-650 Herbal Dietary Supplement (700mg) sold in 60-capsule pouches under UPC 042535355019.
  2. Check your product packaging for batch number IN-032 and an expiration date of 11/30/2027 to see if your supplement is included in this recall.
  3. If you have health concerns after using this product, contact your healthcare provider or pharmacist immediately. Return any unused product to the place of purchase for a refund, throw it away, or contact Guru Inc. at 872-216-1566 or visit www.dalayurevda.com for further instructions.
  4. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) if you have additional questions or want to report an adverse reaction.

Your Remedy Options

You have 2 options:

💰Option 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
🗑️Option 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Infla-650 Herbal Dietary Supplement (700mg)
Variants: 60 capsules, 700mg
UPC Codes:
042535355019
Lot Numbers:
IN-032 (Exp 11/30/2027)

Distributed by Guru Inc. Made in India.

Product Images

“Label Infla-650 Herbal Dietary Supplement 60 Capsules, Batch No IN-032 Exp Date NOV 2027”

“Label Infla-650 Herbal Dietary Supplement 60 Capsules, Batch No IN-032 Exp Date NOV 2027”

“Image of capsules in clear and silver pouch”

“Image of capsules in clear and silver pouch”

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 94893
Status: Active
Manufacturer: Guru Inc.
Sold By: Guru Inc.; Retailers in South Carolina; Retailers in North Carolina; Retailers in Ohio; dalayurevda.com
Manufactured In: India
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · FDA Press Release · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.